|
Re: RESVERLOGIX ANNOUNCES PUBLICATION OF KEY APABETALONE STUDY BETONMACE IN THE JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
|
2
|
Resverlogix Corp.
|
Apr 01, 2020 02:28PM
|
|
Re: RESVERLOGIX ANNOUNCES PUBLICATION OF KEY APABETALONE STUDY BETONMACE IN THE JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
|
1
|
Resverlogix Corp.
|
Mar 31, 2020 04:27PM
|
|
Re: RESVERLOGIX ANNOUNCES PUBLICATION OF KEY APABETALONE STUDY BETONMACE IN THE JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
|
|
Resverlogix Corp.
|
Mar 30, 2020 09:26AM
|
|
Re: RESVERLOGIX ANNOUNCES PUBLICATION OF KEY APABETALONE STUDY BETONMACE IN THE JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
|
|
Resverlogix Corp.
|
Mar 31, 2020 06:51PM
|
|
Re: RESVERLOGIX ANNOUNCES PUBLICATION OF KEY APABETALONE STUDY BETONMACE IN THE JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
|
|
Resverlogix Corp.
|
Mar 31, 2020 07:13PM
|
|
Re: Resverlogix Announces Private Placement
|
2
|
Resverlogix Corp.
|
Aug 16, 2020 11:01AM
|
|
Re: Resverlogix Announces New Insights into the Mechanism of Apabetalone's Cardioprotective Benefit in Chronic Kidney Disease Patients
|
1
|
Resverlogix Corp.
|
Jun 14, 2023 07:25AM
|
|
Re: Resverlogix Announces Corporate Update Conference Call ... Bear
|
|
Resverlogix Corp.
|
Jun 07, 2020 11:49AM
|
|
Re: Resverlogix Announces Corporate Update Conference Call ... Bear
|
|
Resverlogix Corp.
|
Jun 07, 2020 12:47PM
|
|
Re: Resverlogix Announces Corporate Update Conference Call ... Bear
|
1
|
Resverlogix Corp.
|
Jun 07, 2020 01:31PM
|
|
Re: Resverlogix Announces Corporate Update Conference Call ... Bear
|
1
|
Resverlogix Corp.
|
Jun 07, 2020 05:52PM
|
|
Re: Resverlogix Announces Commencement of Patient Enrollment and Dosing in a Phase 2b Trial for a Promising Canadian-Developed COVID-19 Treatment
|
6
|
Resverlogix Corp.
|
Jan 18, 2022 09:52AM
|
|
Re: Resverlogix Announces Apabetalone Prior to SARS-CoV-2 (COVID-19) Exposure Reduces Viral Infection – Confirms Plans for COVID-19 Clinical Trial
|
2
|
Resverlogix Corp.
|
Dec 22, 2020 09:40AM
|
|
Re: Resverlogix Announces Annual and Special Meeting of Shareholders
|
|
Resverlogix Corp.
|
Aug 22, 2019 07:53PM
|
|
Re: Resverlogix Announces a Favorable Outlook Based on New Cardiovascular Disease Treatment Guidelines for Patients with Type 2 Diabetes
|
4
|
Resverlogix Corp.
|
Aug 29, 2023 03:00PM
|
|
Re: Resverlogix AGM webcast 9/12/2018
|
1
|
Resverlogix Corp.
|
Sep 10, 2018 09:24PM
|
|
Re: Resverlogix AGM webcast 9/12/2018
|
1
|
Resverlogix Corp.
|
Sep 11, 2018 06:39AM
|
|
Re: Response from Sarah -were still a go
|
3
|
Resverlogix Corp.
|
Dec 02, 2021 01:09PM
|
|
Re: Response - opp next agm? Brutal imo
|
3
|
Resverlogix Corp.
|
Feb 27, 2024 05:37AM
|
|
Re: Response & what I will attempt...
|
3
|
Zenith Epigenetics
|
Aug 15, 2020 02:02PM
|
